New UT Cancer Drug Stimulates Immune Response Against Tumors

Want the full story?
Read the complete article at KTSM
AI Summary
Researchers at the University of Texas have developed an experimental cancer drug that prompts the immune system to treat tumors as if they were viral infections. This innovative approach aims to enhance the body's natural defenses against cancer by tricking it into recognizing cancer cells as threats. The significance of this development lies in its potential to improve treatment outcomes for cancer patients. Clinical trials are expected to begin soon, offering hope for more effective therapies in the fight against cancer.
Key Details: • University of Texas researchers are developing a new cancer drug. • The drug encourages the immune system to attack tumors like viruses. • Clinical trials are anticipated to start in the near future.